American Oncology Partners of Maryland — Bethesda, Maryland

American Oncology Partners of Maryland is a clinical research site located in Bethesda, Maryland, United States 20817.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

American Oncology Partners of Maryland has participated in 9 clinical trials with 6 currently active.

Therapeutic areas: Follicular Lymphoma, Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia.

Sponsors: Dr. Reddy's Laboratories Limited, Adaptive Biotechnologies, Napo Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bethesda

Browse all research sites in Maryland · View every site in Bethesda

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for American Oncology Partners of Maryland?

American Oncology Partners of Maryland has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has American Oncology Partners of Maryland conducted?

American Oncology Partners of Maryland has 9 clinical trials on record, with 6 currently active. Their work covers Follicular Lymphoma, Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia.

Is American Oncology Partners of Maryland accredited by Crixeo Clinical Trials?

American Oncology Partners of Maryland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about American Oncology Partners of Maryland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.